Advanced search×
×

European Journal of Pharmacology

Print ISSN
0014-2999
Electronic ISSN
1879-0712
Impact factor
2.737
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/00142999
Usage rank
324
Article count
29955
Free count
75
Free percentage
0.00250376
PDFs via platforms
Ingenta, Sciencedirect, Gale, Proquest, CSA, and Rcgp

  1. Editorial Board
    Author(s) unavailable

    European Journal of Pharmacology 747:ii (2015)

  2. Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels.

    European Journal of Pharmacology 590(1-3):317 (2008) PMID 18573250

    We investigate the effects of tanshinone IIA on human KCNQ1/KCNE1 potassium channels (I(Ks)), human ether-a-go-go-related gene potassium channels (hERG), Kv1.5 potassium channels, inward rectifier potassium channels (I(K1)) expressed in HEK 293 cells using patch clamp technique. Tanshinone IIA poten...
  3. Mycophenolate mofetil prevents autoimmune glomerulonephritis and alterations of intrarenal adrenomedullin in rats

    European Journal of Pharmacology 489(1):127 (2004)

    We studied the effects of mycophenolate mofetil, a specific inhibitor of inosine monophosphate dehydrogenase, on the mercuric chloride induced autoimmune glomerulonephritis in Brown Norway rats and also on the renal contents of adrenomedullin. In the rats with autoimmune glomerulonephritis, plasma a...
  4. Announcement
    Author(s) unavailable

    European Journal of Pharmacology 294(1):367 (1995)

  5. The effects of cholinesterase inhibitors on the body temperature of the rat.

    European Journal of Pharmacology 4(1):18 (1968) PMID 5680366

  6. Blockade of NMDA receptors reverses the depressant, but not anxiogenic effect of adolescence social isolation in mice.

    European Journal of Pharmacology 750C:160 (2015) PMID 25592321

    We applied subeffective doses of antagonists including ketamine (1mg/kg), MK-801 (0.05mg/kg), and magnesium sulfate (10mg/kg) to both SC and IC mice prior to behavioral experiments. Administration of a single dose of all mentioned drugs did not affect the SC mice but modulated the depressant effects...
  7. Differential contribution of Gαi/o subunits in the response to food deprivation.

    European Journal of Pharmacology 750C:27 (2015) PMID 25620129

    We observed the effect of the α-subunit silencing on food consumption as soon as 15min after food readministration, that was still significant after 60min. At the highest effective doses, different for each anti-Gαi/o subunit, any treatment did not impair motor coordination, nor modified spontaneous...
  8. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats.

    European Journal of Pharmacology 750C:90 (2015) PMID 25625658

    Diabetic nephropathy becomes the single most frequent cause of end-stage renal disease. The present study aimed therefore to investigate possible protective effect of eprosartan, an angiotensin II type 1 receptor blocker, on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats and...
  9. Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation

    European Journal of Pharmacology 752:78 (2015)

    We report the design and synthesis of novel hybrids of caffeic acid phenetyl ester (CAPE) and non-steroidal anti-inflammatory drugs (NSAIDs). We assessed their effects on an experimental ocular inflammation in New Zealand rabbits. The formulations of CAPE–aspirin and CAPE–indomethacin hybrids were t...
  10. Management of Parkinson׳s disease: Current and future pharmacotherapy

    European Journal of Pharmacology 750:74 (2015)

    Parkinson׳s disease (PD) is chronic progressive neurodegenerative disorder characterized by profound loss of dopaminergic neurons in the nigrostriatal pathway. It is recognized by the cardinal clinical features of bradykinesia, rigidity, tremor and postural instability. Current therapeutic...